{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:13:01Z","timestamp":1794107581913,"version":"4.8.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ50447"],"award-info":[{"award-number":["2023JJ50447"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2025JJ70490"],"award-info":[{"award-number":["2025JJ70490"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2025JJ70453"],"award-info":[{"award-number":["2025JJ70453"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Huaihua Philosophy and Social Sciences Achievements Assessment Committee","award":["HSP2025090"],"award-info":[{"award-number":["HSP2025090"]}]},{"name":"the Health Commission Program of Hunan Province","award":["D202313018595"],"award-info":[{"award-number":["D202313018595"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12952-0","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:09:21Z","timestamp":1772453361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association between low-dose trimethoprim-sulfamethoxazole blood concentration and clinical outcomes in non-HIV patients with Pneumocystis jirovecii pneumonia: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ziwei","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinque","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"12952_CR1","doi-asserted-by":"publisher","first-page":"680108","DOI":"10.3389\/fpubh.2021.680108","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhou X, Saimi M, et al. Risk factors of mortality from pneumocystis pneumonia in non-HIV patients: a meta-analysis. Front Public Health. 2021;9:680108.","journal-title":"Front Public Health"},{"issue":"1","key":"12952_CR2","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/s41598-017-01818-w","volume":"7","author":"SH Lee","year":"2017","unstructured":"Lee SH, Huh KH, Joo DJ, et al. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients. Sci Rep. 2017;7(1):1571.","journal-title":"Sci Rep"},{"issue":"9","key":"12952_CR3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S2213-2600(25)00125-0","volume":"13","author":"V Lemiale","year":"2025","unstructured":"Lemiale V, Resche-Rigon M, Zerbib Y, et al. Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial. Lancet Respiratory Med. 2025;13(9):800\u20138.","journal-title":"Lancet Respiratory Med"},{"issue":"12","key":"12952_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1542\/pir.2022-005516","volume":"44","author":"A Noor","year":"2023","unstructured":"Noor A, Krilov LR. Pneumocystis pneumonia. Pediatr Rev. 2023;44(12):720\u20132.","journal-title":"Pediatr Rev"},{"issue":"9","key":"12952_CR5","doi-asserted-by":"publisher","first-page":"e13587","DOI":"10.1111\/ctr.13587","volume":"33","author":"JA Fishman","year":"2019","unstructured":"Fishman JA, Gans H, AST Infectious Diseases Community of Practice. Pneumocystis jiroveci in solid organ transplantation: guidelines from the american society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13587.","journal-title":"Clin Transplant"},{"issue":"9","key":"12952_CR6","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1093\/jac\/dkw158","volume":"71","author":"G Maschmeyer","year":"2016","unstructured":"Maschmeyer G, Helweg-Larsen J, Pagano L, et al. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. J Antimicrob Chemother. 2016;71(9):2405\u201313.","journal-title":"J Antimicrob Chemother"},{"key":"12952_CR7","doi-asserted-by":"crossref","unstructured":"Schulz M, Schmoldt A, Andresen-Streichert H, et al. Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Critical Care (London, England). 2020;24(1):195.","DOI":"10.1186\/s13054-020-02915-5"},{"issue":"6","key":"12952_CR8","first-page":"1653","volume":"21","author":"PAN Huan-yan","year":"2023","unstructured":"Huan-yan PAN, Hui QI, Pei LIANG, et al. Concentration monitoring of compound sulfamethoxazole in patients with severe pneumocystis jasinii pneumonia. Cent South Pharm. 2023;21(6):1653\u20138 (in Chinese).","journal-title":"Cent South Pharm"},{"issue":"1","key":"12952_CR9","first-page":"51","volume":"19","author":"SHU Yang","year":"2024","unstructured":"Yang SHU, Xiaoshuang HE. Clinical significance of plasma peak concentration determination of compound sulfamethoxazole in treatment of Pneumocystis jirovecii pneumonia in patients with non\u2043human immunodeficiency virus infection. J Intern Med Concepts Pract. 2024;19(1):51\u20136 (in Chinese).","journal-title":"J Intern Med Concepts Pract"},{"issue":"6","key":"12952_CR10","doi-asserted-by":"publisher","first-page":"W555","DOI":"10.2214\/AJR.11.7329","volume":"198","author":"JP Kanne","year":"2012","unstructured":"Kanne JP, Yandow DR, Meyer CA. Pneumocystis jiroveci pneumonia: high-resolution CT findings in patients with and without HIV infection. AJR Am J Roentgenol. 2012;198(6):W555\u2013561.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"12952_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s40249-020-00768-2","volume":"9","author":"CJ Du","year":"2020","unstructured":"Du CJ, Liu JY, Chen H, et al. Differences and similarities of high-resolution computed tomography features between pneumocystis pneumonia and cytomegalovirus pneumonia in AIDS patients. Infect Dis Poverty. 2020;9(1):149.","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"12952_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4046\/trd.2020.0015","volume":"83","author":"S Tasaka","year":"2020","unstructured":"Tasaka S. Recent advances in the diagnosis and management of pneumocystis pneumonia. Tuberc Respir Dis. 2020;83(2):132\u201340.","journal-title":"Tuberc Respir Dis"},{"issue":"2","key":"12952_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/clinids\/4.2.566","volume":"4","author":"GR Siber","year":"1982","unstructured":"Siber GR, Gorham CC, Ericson JF, et al. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function. Rev Infect Dis. 1982;4(2):566\u201378.","journal-title":"Rev Infect Dis"},{"issue":"9","key":"12952_CR14","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1128\/AAC.35.9.1884","volume":"35","author":"RC Stevens","year":"1991","unstructured":"Stevens RC, Laizure SC, Williams CL, et al. Pharmacokinetics and adverse effects of 20-mg\/kg\/day trimethoprim and 100-mg\/kg\/day sulfamethoxazole in healthy adult subjects. Antimicrob Agents Chemother. 1991;35(9):1884\u201390.","journal-title":"Antimicrob Agents Chemother"},{"key":"12952_CR15","doi-asserted-by":"crossref","unstructured":"Park JW, Curtis JR, Kim MJ, et al. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole. Arthritis Res Ther. 2019;21(1):207.","DOI":"10.1186\/s13075-019-1996-6"},{"issue":"6","key":"12952_CR16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"MH Abdul-Aziz","year":"2020","unstructured":"Abdul-Aziz MH, Alffenaar JWC, Bassetti M, et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper. Intensive Care Med. 2020;46(6):1127\u201353.","journal-title":"Intensive Care Med"},{"issue":"7","key":"12952_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/jpm15070311","volume":"15","author":"IE Dimeas","year":"2025","unstructured":"Dimeas IE, Dimeas GE, Zakynthinos GE, et al. Individualized trimethoprim-sulfamethoxazole dosing in non-HIV patients with pneumocystis pneumonia: a narrative review of current evidence. J Personalized Med. 2025;15(7):311.","journal-title":"J Personalized Med"},{"issue":"1","key":"12952_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.chest.2023.08.009","volume":"165","author":"T Nagai","year":"2024","unstructured":"Nagai T, Matsui H, Fujioka H, et al. Low-dose vs conventional-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in patients not infected with HIV: a multicenter, retrospective observational cohort study. Chest. 2024;165(1):58\u201367.","journal-title":"Chest"},{"issue":"12","key":"12952_CR19","doi-asserted-by":"publisher","first-page":"e01173","DOI":"10.1128\/AAC.01173-17","volume":"61","author":"M Kosaka","year":"2017","unstructured":"Kosaka M, Ushiki A, Ikuyama Y, et al. A four-center retrospective study of the efficacy and toxicity of low-dose trimethoprim-sulfamethoxazole for the treatment of pneumocystis pneumonia in patients without HIV infection. Antimicrob Agents Chemother. 2017;61(12):e01173\u201317.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"12952_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jiac.2018.11.014","volume":"25","author":"SI Ohmura","year":"2019","unstructured":"Ohmura SI, Naniwa T, Tamechika SY, et al. Effectiveness and safety of lower dose sulfamethoxazole\/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: a retrospective multicenter study. J Infect Chemotherapy: Official J Japan Soc Chemother. 2019;25(4):253\u201361.","journal-title":"J Infect Chemotherapy: Official J Japan Soc Chemother"},{"issue":"1","key":"12952_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12879-024-09031-7","volume":"24","author":"H Li","year":"2024","unstructured":"Li H, Lu Y, Tian G, et al. A regimen based on the combination of trimethoprim\/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related Pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital. BMC Infect Dis. 2024;24(1):152.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"12952_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12879-023-08372-z","volume":"23","author":"H Qi","year":"2023","unstructured":"Qi H, Dong D, Liu N, et al. Efficacy of initial caspofungin plus trimethoprim\/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection. BMC Infect Dis. 2023;23(1):409.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12952-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12952-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12952-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:03:13Z","timestamp":1775566993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12952-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12952"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12952-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Hunan University of Medicine General Hospital (Ethics approval number: KY-2026010902). Given that this study used only retrospective, fully anonymized medical data and posed no risk to the participants, the requirement for obtaining individual written informed consent was waived by the Medical Ethics Committee of Hunan University of Medicine General Hospital. All procedures performed in this study were in accordance with the Declaration of Helsinki and relevant ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"725"}}